Identification of bacteria-derived HLA-bound peptides in melanoma

Shelly Kalaora; Adi Nagler; Deborah Nejman; Michal Alon; Chaya Barbolin; Eilon Barnea; Steven L. C. Ketelaars; Kuoyuan Cheng; Kévin Vervier; Noam Shental; Yuval Bussi; Ron Rotkopf; Ronen Levy; Gil Benedek; Sophie Trabish; Tali Dadosh; Smadar Levin‐Zaidman; Leore T. Geller; Kun Wang; Polina Greenberg; Gal Yagel; Aviyah Peri; Garold Fuks; Neerupma Bhardwaj; Alexandre Reuben; Leandro C. Hermida; Sarah B. Johnson; Jessica Galloway-Peña; William C. Shropshire; Chantale Bernatchez; Cara Haymaker; Reetakshi Arora; Lior Roitman; Raya Eilam; Adina Weinberger; Maya Lotan‐Pompan; Michal Lotem; Arie Admon; Yishai Levin; Trevor D. Lawley; David J. Adams; Mitchell P. Levesque; Michal J. Besser; Jacob Schachter; Ofra Golani; Eran Segal; Naama Geva‐Zatorsky; Eytan Ruppin; Pia Kvistborg; Scott N. Peterson; Jennifer A. Wargo; Ravid Straussman; Yardena Samuels

doi:10.1038/s41586-021-03368-8

Identification of bacteria-derived HLA-bound peptides in melanoma

Shelly Kalaora(Weizmann Institute of Science), Adi Nagler(Weizmann Institute of Science), Deborah Nejman(Weizmann Institute of Science), Michal Alon(Weizmann Institute of Science), Chaya Barbolin(Weizmann Institute of Science), Eilon Barnea(Technion – Israel Institute of Technology), Steven L. C. Ketelaars(The Netherlands Cancer Institute), Kuoyuan Cheng(National Institutes of Health), Kévin Vervier(Wellcome Sanger Institute), Noam Shental(Open University of Israel), Yuval Bussi(Weizmann Institute of Science), Ron Rotkopf(Weizmann Institute of Science), Ronen Levy(Weizmann Institute of Science), Gil Benedek(Hadassah Medical Center), Sophie Trabish(Weizmann Institute of Science), Tali Dadosh(Weizmann Institute of Science), Smadar Levin‐Zaidman(Weizmann Institute of Science), Leore T. Geller(Weizmann Institute of Science), Kun Wang(National Institutes of Health), Polina Greenberg(Weizmann Institute of Science), Gal Yagel(Weizmann Institute of Science), Aviyah Peri(Weizmann Institute of Science), Garold Fuks(Weizmann Institute of Science), Neerupma Bhardwaj(Technion – Israel Institute of Technology), Alexandre Reuben(The University of Texas MD Anderson Cancer Center), Leandro C. Hermida(National Institutes of Health), Sarah B. Johnson(The University of Texas MD Anderson Cancer Center), Jessica Galloway-Peña(Texas A&M University), William C. Shropshire(The University of Texas MD Anderson Cancer Center), Chantale Bernatchez(The University of Texas MD Anderson Cancer Center), Cara Haymaker(The University of Texas MD Anderson Cancer Center), Reetakshi Arora(The University of Texas MD Anderson Cancer Center), Lior Roitman(Weizmann Institute of Science), Raya Eilam(Weizmann Institute of Science), Adina Weinberger(Weizmann Institute of Science), Maya Lotan‐Pompan(Weizmann Institute of Science), Michal Lotem(Hadassah Medical Center), Arie Admon(Technion – Israel Institute of Technology), Yishai Levin(Weizmann Institute of Science), Trevor D. Lawley(Wellcome Sanger Institute), David J. Adams(Wellcome Sanger Institute), Mitchell P. Levesque(University of Zurich), Michal J. Besser(Tel Aviv University), Jacob Schachter(Tel Aviv University), Ofra Golani(Weizmann Institute of Science), Eran Segal(Weizmann Institute of Science), Naama Geva‐Zatorsky(Canadian Institute for Advanced Research), Eytan Ruppin(National Institutes of Health), Pia Kvistborg(The Netherlands Cancer Institute), Scott N. Peterson(Sanford Burnham Prebys Medical Discovery Institute), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Ravid Straussman(Weizmann Institute of Science), Yardena Samuels(Weizmann Institute of Science)

Nature

March 17, 2021

10.1038/s41586-021-03368-8

Cited by 434Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis